This website is intended to provide information to a German audience only. You may continue browsing in this region or go to the website intended for your location.

Maquet Internetseiten erfassen pseudonymisiert bzw. anonymisiert statistische Informationen, die der Optimierung angebotener Funktionen und Leistungen dienen. Wenn Sie unser Angebot nutzen, setzen wir Ihr stillschweigendes Einverständnis zur Nutzung dieser Daten voraus. Weitere Informationen und wie Sie unsere Seiten anonym nutzen können, finden Sie in unserer Datenschutzerklärung.

Counterpulsation Therapy - Should we continue to use it?

The intra-aortic balloon pump (IABP) is a well-known, frequently used tool in interventional cardiology and has long been the first-line choice for mechanical circulatory support. Recent debate regarding the IABP has centered on the discrepant results obtained from randomized trials. The purpose of this session is to answer the question: Should we continue to use it?

The session will highlight the effect of counterpulsation on coronary perfusion with exhausted autoregulation; the effect of a larger volume (50cc) IAB on left ventricular unloading; and discuss real-world case studies in the complex coronary patient and patients with AMI complicated by persistent ischemia.

Clinical trial Data in IABP Therapy

Dr. Divaka Perera and Dr. Mark Cohen wrap up the 2015 Euro PCR and discuss intra-aortic balloon pumping and why we should continue to use it in 2015.